Also trades as: NRSNW (NASDAQ) · $vol 0M
NRSN NASDAQ
NeuroSense Therapeutics Ltd.
1W: -17.8%
1M: -24.0%
3M: -23.3%
YTD: -26.2%
1Y: -71.7%
3Y: -58.0%
$0.56
-0.03 (-4.89%)
Weekly Expected Move ±6.6%
$1
$1
$1
$1
$1
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$19.7M
52W Range0.515-2.09
Volume504,055
Avg Volume159,678
Beta1.56
Dividend—
Analyst Ratings
Company Info
CEOAlon Ben-Noon
Employees17
SectorHealthcare
IndustryBiotechnology
IPO Date2021-12-09
Websiteneurosense-tx.com
Building B
Herzliya, TA 4672562
IL
Herzliya, TA 4672562
IL
972 9 799 6183
About NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical development phase, committed to discovering and developing effective therapies for individuals suffering from severe neurodegenerative conditions. The company's leading drug candidate, PrimeC, is an innovative oral formulation that has successfully concluded Phase IIa clinical investigations for the management of amyotrophic lateral sclerosis (ALS). Additionally, its early-stage research pipeline features StabiliC, a potential treatment for Parkinson's disease, and CogniC, which is under development for Alzheimer's disease. Established in 2017, NeuroSense Therapeutics Ltd. is headquartered in Herzliya, Israel.
Latest News
12 Health Care Stocks Moving In Wednesday's After-Market Session
12 Health Care Stocks Moving In Tuesday's After-Market Session
NeuroSense Therapeutics receives Nasdaq notices over listing requirements
NeuroSense Therapeutics reports FY results, GAAP EPS of $0.44
NeuroSense Therapeutics Reports Year End 2025 Financial Results and Provides Business Update
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Eisenberg Or | P-Purchase | 250,000 | $0.80 | 2026-06-16 |
| Ben-Noon Alon | P-Purchase | 250,000 | $0.80 | 2026-06-16 |
| Eisenberg Or | A-Award | 200,000 | — | 2026-03-26 |
| Russek-Blum Niva | A-Award | 200,000 | — | 2026-03-26 |
| Binder Hagit | A-Award | 200,000 | — | 2026-03-26 |